Replay available

Madrigal Pharmaceuticals, Inc. (MDGL) Q3 2025 Earnings Call

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

Tue, November 4, 2025 at 8:00 AMendedReplay
Madrigal Pharmaceuticals, Inc. (MDGL) Q3 2025 Earnings Call

Hosted by

Featured presenters

Tina Ventura

Chief Investor Relations Officer

Bill Sibyl

Chief Executive Officer

Dave Sorgel

Chief Medical Officer

Marty Deer

Chief Financial Officer

Yasmeen Rahimi

Analyst, Piper Sandler

Jay Olson

Analyst, Oppenheimer

Michael DeFore

Analyst, Evercore ISI

Akash Tiwari

Analyst, Jefferies

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Madrigal Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.034 Good morning, and thank you for standing by. 00:00:02.034 -- 00:00:07.440 Welcome to the Magical Pharmaceuticals Third Quarter 2025 Earnings Conference Call. 00:00:07.440 -- 00:00:10.684 At this time, all participants are in listen-only mode. 00:00:10.684 -- 00:00:14.369 After the speaker's presentation, there will be a question and answer session. 00:00:14.369 -- 00:00:17.853 As a reminder, today's conference call is being recorded. 00:00:17.853 -- 00:00:21.598 I'd like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. 00:00:21.598 -- 00:00:23.959 Please go ahead. 00:00:24.061 -- 00:00:28.450 Thanks, Marvin. Good morning, everyone, and thank you for joining us to discuss Madrigal's 00:00:28.450 -- 00:00:31.591 third quarter 2025 earnings. 00:00:31.693 -- 00:00:35.418 We issued a press release this morning and posted a slide deck that accompanies this 00:00:35.418 -- 00:00:39.402 webcast on the investor relations section of our website. 00:00:39.402 -- 00:00:44.768 On the call with me today is Bill Sibyl, Chief Executive Officer, Dave Sorgel, 00:00:44.768 -- 00:00:49.593 Chief Medical Officer, and Marty Deer, Chief Financial Officer. 00:00:49.593 -- 00:00:54.149 They will provide prepared remarks, and then we'll take your questions. 00:00:54.149 -- 00:00:59.034 Please note on slide two, we will be making certain forward-looking statements today. 00:00:59.034 -- 00:01:04.340 We refer you to our SEC filings for a discussion of the risks that may cause actual 00:01:04.340 -- 00:01:06.963 results to differ from the forward-looking statements. 00:01:06.963 -- 00:01:09.926 With that, I will now turn the call over to Bill. 00:01:09.926 -- 00:01:12.989 Thanks, Tina. Good morning and thanks for joining us. 00:01:12.989 -- 00:...